Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21180911 | 0.89 | ALDH1A1 (0.68) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL22725787 | 0.89 | ALDH1A1 (0.62) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL26506897 | 0.86 | ALDH1A1 (0.43) | ALDH1A1PKMPOLBSMN1; SMN2 | |
| SCHEMBL6031551 | 0.84 | ALDH1A1 (0.36) | ALDH1A1PKMPOLB | |
| SCHEMBL26936249 | 0.82 | ALDH1A1 (0.39) | ALDH1A1PKMPOLBSMN1; SMN2 | |
| SCHEMBL13377043 | 0.80 | ALDH1A1 (0.80) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL21500122 | 0.78 | ALDH1A1 (0.54) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL6375310 | 0.78 | ALDH1A1 (0.54) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL25800801 | 0.78 | ALDH1A1 (0.54) | ALDH1A1PKMPOLBSMN1; SMN2MAPT | |
| SCHEMBL26505844 | 0.75 | POLB (0.50) | ALDH1A1PKMPOLBSMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177508-B2 | Lithium-ion battery and apparatus | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2021-11-16 | — | — | US | disclosed |
| US-11152643-B2 | — | — | 2021-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177508-B2 | Lithium-ion battery and apparatus | LMNB1, HVCN1, NAP1L1 | ALDH1A1 1841/4885PKM 3850/4885POLB 339/4885 |
| US-11152643-B2 | — | HVCN1, NAP1L1, LMNB1 | ALDH1A1 2037/4885PKM 3614/4885POLB 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.